文献速递乳房整形与再造创面修复

乳房切除术后组织扩张器置入常规术后抗生素不改善结局

Routine Postoperative Antibiotics After Tissue Expander Placement Postmastectomy Does Not Improve Outcome.
PubMed 文献 · Ann Plast Surg · 2021-01-01

该回顾性研究纳入2005年6月至2018年9月共529例即时组织扩张器置入患者,比较围手术期抗生素组(A组241例)与延长口服抗生素至少7天组(B组288例)。结果显示两组感染率分别为23.24%和21.53%(P=0.412),其他并发症无显著差异,常规术后抗生素未减少并发症或改善结局。

要点

  • 术后延长抗生素未降低感染率(23.24% vs 21.53%,P=0.412)。
  • 其他并发症如伤口问题、血肿、血清肿等两组趋势相似。
  • 常规术后抗生素对即时组织扩张器重建无额外获益。

核心结论

  • 常规术后抗生素不减少组织扩张器置入后常见并发症或改善临床结局。

研究设计与样本

  • 回顾性图表 review,纳入2005年6月至2018年9月共529例即时组织扩张器置入患者,A组241例(398只乳房),B组288例(466只乳房),随访至术后5个月。

主要发现

  • A组感染率23.24%,B组21.53%(P=0.412)。
  • 其他并发症比较趋势与感染相似,无统计学显著差异。
  • 两组人口学及危险因素(放疗、化疗、吸烟、糖尿病)无显著差异。

关键数值与推荐

  • 所有患者术前30-60分钟及术后24小时接受围手术期静脉抗生素。
  • B组额外口服抗生素至少7天。
  • 感染率A组23.24% vs B组21.53%(P=0.412)。

临床怎么用

  • 即时乳房切除重建组织扩张器置入时,可考虑仅用围手术期抗生素,避免常规延长术后抗生素。

局限性

  • 回顾性设计,随访仅至术后5个月,可能遗漏晚期并发症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: In an attempt to reduce the incidence of infectious complications after tissue expander-based breast reconstruction, the routine administration of postoperative antibiotics regimen is common in many practices. In recent years, there has been a plethora of reports scrutinizing the prophylactic use of postoperative antibiotics in this setting. The aim of this study was to determine the efficacy of prolonged administration of postoperative antibiotics compared with perioperative-only antibiotic administration for prophylaxis after tissue expander placement for immediate mastectomy reconstruction. METHODS AND MATERIALS: A retrospective chart review of all patients who underwent immediate tissue expander placement after mastectomy at our institution from June 2005 to September 2018 was performed. All patients in the study received perioperative intravenous antibiotics 30 to 60 min preoperatively and for 24 hours postoperatively. Patients were divided into 2 groups. Patients in group A did not receive antibiotics beyond the perioperative period. Patients in group B received oral antibiotics for at least 7 days postoperatively in addition to the perioperative intravenous antibiotics. The 2 groups were compared for demographics and prevalence of risk factors such as radiation, chemotherapy, smoking, and diabetes. The incidence of complications such as infection, wound complications, hematoma, seroma, capsular contracture, loss of tissue expander, and reoperations was assessed. SUMMARY OF RESULTS: A total of 529 patients were included in the study, of which 241 were in group A and 288 were in group B. The total number of breasts reconstructed in group A was 398, whereas in group B, it was 466 breasts. Patients were followed up to 5 months postoperatively in each group. There were no statistically significant differences in the demographic and patient characteristics among the 2 groups. The incidence of infection in group A was 23.24% and in group B was 21.53% (P = 0.412). The incidence of other complications follows the same trend when comparing group A versus B. CONCLUSIONS: This retrospective study shows that the routine use of postoperative antibiotics after tissue expander placement for immediate mastectomy reconstruction does not result in reduction in the incidence of common complications or improvement of clinical outcomes.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Yamin F, Nouri A, McAuliffe P, et al. Routine Postoperative Antibiotics After Tissue Expander Placement Postmastectomy Does Not Improve Outcome. Ann Plast Surg. 2021. PMID: 33833164. doi:10.1097/SAP.0000000000002826

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。